2022 annual financial data
Senti Biosciences Holdings 2022 Operating cash flow
Direct answer
Operating cash flow was -34,896,000 USD.
Operating income was -70,629,000 USD and net income was -45,791,000 USD.
Operating cash flow was -34,896,000 USD.
Get free Senti Biosciences Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,286,000 USD
- Operating income
- -70,629,000 USD
- Net income
- -45,791,000 USD
- Operating cash flow
- -34,896,000 USD